Going Global: International Export

and EU Clinical Regulatory Considerations

PorterWright
BioOhio-Logo-2016-20cm
RJR-Consulting

Join BioOhio, Porter Wright, and RJR Consulting for Going Global: International Export and EU Clinical Regulatory Considerations, a program designed for international trade attorneys, regulatory professionals, and business executives interested in learning the basics of exporting to the European Union (EU), and understanding the regulatory environment of medical devices and pharmaceuticals in the EU.

In today’s global marketplace, an understanding of international trade, foreign laws, regulatory environment, and international standards is a must. Global marketers must deal not only with the legal elements of traditional trade issues such as customs duties, but also with an array of complex laws that can affect market access around the world. Product standards, conducting clinical trials, international clinical trials data, package labeling requirements, environmental protection mandates, privacy laws, and other international, regional, or national regulations can effectively restrict a company’s ability to conduct business in international markets.

As updating staff skills is becoming increasingly important, attending this event will give you strategies and understanding that will help you compete more effectively in the global market.

April 2018

Columbus, OH, 1:00 to 5:00 PM

Cost

BioOhio Members (1-10 employees) – $95

BioOhio Members (11+ employees) – $119

Non Members – $219

Government – $95

Agenda

1:00 PM – 1:20 Registration & Networking

1:20 – 1:30 Welcome & Opening Remarks

John F. Lewis, Jr., President & CEO, BioOhio

  • Highlight the current statistics of Ohio’s growing bioscience industry

1:30 – 2:15 Overview of EU legal issues for new exporters

Presented by Porter Wright Partners Dixon MillerBrett ThorntonMark SniderWilliam Sjoberg, and Christina Hultsch.  

  • International contracting/commercial transactions/E Commerce
  • Funds transfers from foreign countries/letters of credit and shipping
  • U.S. Export controls
  • Foreign country customs and import controls
  • Multiple country taxation issues
  • Dispute resolution issues/GDPR/privacy data protection

2:15 – 3:00 Potential Strategies

Presented by Porter Wright Partners Dixon MillerBrett Thornton, and Mark Snider. 

  • Use of Sales Representatives
    • Advantages/disadvantages of using sales representatives
    • Laws governing sales representatives in different jurisdictions
  • Joint marketing agreements
  • Deciding when to form a foreign subsidiary

3:00 – 3:15 Networking Break

3:15 – 4:00 Going Global – International Regulatory and Business Considerations & Opportunities

Jim Russell, Director of International Projects, Regulatory Affairs Consultant, RJR Consulting

Medical device and pharmaceutical companies of all sizes are attempting to increase revenues by taking their products to other global markets. For the unprepared, this daunting task is usually met with pitfalls, roadblocks and significant regulatory challenges.  Knowing when and how to legally enter a new global market is a key driver to a successful business expansion.

This presentation will provide general insight to regulatory compliance considerations and regional differences when entering new global markets. We will discuss key elements to consider before, during and after the registration and marketing of pharmaceuticals, devices and biologics in the U.S., the EU, Latin America, Asia Pacific and the Middle East.

  • Introduction to global life science markets
  • Country establishment requirements
  • Product classification
  • Clinical data considerations
  • Manufacturing / Quality considerations
  • Product licensing requirements
  • Labeling requirements
  • Product claims and marketing
  • Import / Export considerations
  • Key regional challenges
    • US, EU, LatAm, Asia Pacific, Middle East
  • Working with Global Authorities

4:00 – 4:45 EU Regulatory Compliance for Life Science Products

Bob Russell, President, RJR Consulting

This session covers the regulatory process necessary to be able to market bioscience products (Pharmaceuticals, Biologics and Medical Devices) in the EU. The presentation will detail the regulatory structure and authorities that exist in the EU along with the pathways and procedures available to obtain the necessary pre-market approvals for each type of product in the EU.

  • EU Agency Regulatory Structure
  • Applicable Regulations
  • Country Establishment requirements
  • Product classification
  • Clinical Studies & the Clinical Trial Regulation
  • GMP & Quality Systems requirements
  • Registration/Marketing Authorization Procedures/CE marking
  • Changes to Marketed Products – Variations / Amendments / Renewals
  • Post-Market Vigilance requirements
  • Compare/Contrast of EU and FDA procedures
  • Impact of Brexit

4:45 Closing Remarks, Networking